Step 1: Completion of Phase 3 Clinical Trials These studies assess: Long term safety and tolerability Consistency of weight loss outcomes Impact on metabolic and cardiovascular markers Real world relevant patient groups Only once sufficient trial evidence exists can a regulatory submission take place
All efficacy and safety data is based on 7-day (once-weekly) intervals
If you have concerns about how Retatrutide might interact with other conditions or medications, learning about insulin resistance and metabolic health provides helpful background for conversations with your healthcare team
Green flags include discussions referencing peer-reviewed studies, acknowledgment of individual variation, and emphasis on provider involvement
Manufacturer : Mounjaro is manufactured by the reputable North American company, Eli Lilly
Based on the mechanism and available evidence, most experts expect acceptable long-term safety, but this remains an area where caution is warranted
